# IonMAN Trial- First in Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System

> **NCT05364697** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Medinol Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Coronary Stenosis
- Coronary Disease
- Non-ST Elevated Myocardial Infarction
- Cardiovascular Diseases

## Interventions

- **DEVICE:** IoNIR Ridaforolimus-Eluting Coronary Stent System

## Key facts

- **NCT ID:** NCT05364697
- **Lead sponsor:** Medinol Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-30
- **Primary completion:** 2024-09-30
- **Final completion:** 2029-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05364697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05364697, "IonMAN Trial- First in Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05364697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*